Brief: Enorama Pharma To Prepare Balance Sheet For Liquidation Purposes
13/02/2026 10:59
Feb 13 (Reuters) - Enorama Pharma AB ERMA.ST: DECIDES TO PREPARE A BALANCE SHEET FOR LIQUIDATION PURPOSES DECISION ENTAILS THAT ASSETS RELATED TO SUBSIDIARY MAY NEED TO BE REVALUED CONSIDERS THAT THERE IS REASON TO BELIEVE THAT COMPANY'S EQUITY IS LESS THAN HALF OF REGISTERED SHARE CAPITAL Source text: ID:nWkr6WxSLs Further company coverage: ERMA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO